Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
0.9000
Dollar change
-0.0017
Percentage change
-0.19
%
Index- P/E- EPS (ttm)-0.73 Insider Own72.95% Shs Outstand166.40M Perf Week-3.33%
Market Cap149.76M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float45.01M Perf Month-6.74%
Enterprise Value155.31M PEG- EPS next Q- Inst Own0.11% Short Float0.20% Perf Quarter9.76%
Income-2.73M P/S- EPS this Y- Inst Trans0.01% Short Ratio0.74 Perf Half Y-92.34%
Sales0.00M P/B- EPS next Y- ROA-17.24% Short Interest0.09M Perf YTD3.52%
Book/sh-3.19 P/C416.00 EPS next 5Y- ROE-62.50% 52W High15.00 -94.00% Perf Year-92.50%
Cash/sh0.00 P/FCF- EPS past 3/5Y-175.18% - ROIC- 52W Low0.56 60.09% Perf 3Y-91.24%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility6.23% 7.40% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-610.86% Oper. Margin- ATR (14)0.08 Perf 10Y-
Dividend Ex-DateFeb 13, 2023 Quick Ratio0.04 Sales Y/Y TTM- Profit Margin- RSI (14)36.22 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.04 EPS Q/Q-1113.92% SMA20-6.01% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA50-7.72% Rel Volume0.08 Prev Close0.90
Employees2 LT Debt/Eq- Earnings- SMA200-88.08% Avg Volume123.80K Price0.90
IPODec 23, 2021 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume10,315 Change-0.19%
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.